Literature DB >> 3033058

Cirrhosis and the aetiology of hepatocellular carcinoma.

P J Johnson, R Williams.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 3033058     DOI： 10.1016/s0168-8278(87)80021-1

Source DB:  PubMed          Journal:  J Hepatol        ISSN： 0168-8278            Impact factor:   25.083


× No keyword cloud information.
  20 in total

Review 1.  Hepatocellular carcinoma. A worldwide problem and the major risk factors.

Authors:  R G Simonetti; C Cammà; F Fiorello; F Politi; G D'Amico; L Pagliaro
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

Review 2.  Advances in neoplastic disease of the liver and biliary tract.

Authors:  P J Johnson; M L Wilkinson; J Karani
Journal:  Gut       Date:  1991-09       Impact factor: 23.059

3.  Risk factors and prevention of hepatocellular carcinoma in HCV infection.

Authors:  L Benvegnù; A Alberti
Journal:  Dig Dis Sci       Date:  1996-12       Impact factor: 3.199

4.  Bioinformatics analysis reveals potential candidate drugs for HCC.

Authors:  Xiao-Bing Huang; Jing Li; Lu Zheng; Guo-Hua Zuo; Ke-Qiang Han; Hong-Yan Li; Ping Liang
Journal:  Pathol Oncol Res       Date:  2013-01-23       Impact factor: 3.201

5.  Occurrence of HCC in asymptomatic HCV-related chronic hepatitis.

Authors:  Marcello Persico; Bruno Palmentieri; Leonardo Coppola; Giovanni Di Giacomo Russo; Fedele De Marino; Ilario De Sio; Roberto Torella
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

6.  Diarrhea as a presenting symptom of hepatocellular carcinoma.

Authors:  J Bruix; A Castells; X Calvet; F Feu; C Bru; M Solé; M Bruguera; J Rodés
Journal:  Dig Dis Sci       Date:  1990-06       Impact factor: 3.199

7.  Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade.

Authors:  Philip J Johnson; Sarah Berhane; Chiaki Kagebayashi; Shinji Satomura; Mabel Teng; Helen L Reeves; James O'Beirne; Richard Fox; Anna Skowronska; Daniel Palmer; Winnie Yeo; Frankie Mo; Paul Lai; Mercedes Iñarrairaegui; Stephen L Chan; Bruno Sangro; Rebecca Miksad; Toshifumi Tada; Takashi Kumada; Hidenori Toyoda
Journal:  J Clin Oncol       Date:  2014-12-15       Impact factor: 44.544

8.  Microvessel density and clinicopathologic characteristics in hepatocellular carcinoma with and without cirrhosis.

Authors:  Ivan Chebib; Meer Taher Shabani-Rad; Michelle S Chow; James Zhang; Zu-Hua Gao
Journal:  Biomark Insights       Date:  2007-02-14

9.  Hepatitis C antibody in patients with chronic liver disease and hepatocellular carcinoma.

Authors:  M Colombo; M G Rumi; M F Donato; M A Tommasini; E Del Ninno; G Ronchi; G Kuo; M Houghton
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199

10.  Role of hepatitis delta virus infection in hepatocellular carcinoma.

Authors:  G Verme; M R Brunetto; F Oliveri; M Baldi; B Forzani; P Piantino; A Ponzetto; F Bonino
Journal:  Dig Dis Sci       Date:  1991-08       Impact factor: 3.199
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.